S-Space College of Medicine/School of Medicine (의과대학/대학원) Preventive Medicine (예방의학전공) Journal Papers (저널논문_예방의학전공)
Costs for 5-year lung cancer survivors in a tertiary care hospital in South Korea
- Park, Young Sik; Kim, Seon Ha; Park, Sue Kyung; Park, Byung-Joo; Lee, Sang-Min; Yoo, Chul-Gyu; Han, Sung Koo; Yang, Seok-Chul; Shim, Young-Soo; Kim, Young Whan; Yim, Jae-Joon; Kim, Young Tae
- Issue Date
- ELSEVIER IRELAND LTD
- LUNG CANCER; Vol.68 2; 299-304
- Lung cancer; Health care costsl; Lung cancer survivorsl; Medical economicsl; Economic burden
- Introduction: As the population of patients with lung cancer increases, the expenditure on lung cancer treatment will become a huge economic burden in many countries. To support public health services for the treatment of lung cancer, the calculation of lung cancer-specific costs is important. Methods: This study included newly diagnosed 76 lung cancer patients who had survived for at least 5 years after the diagnosis in a tertiary care hospital in South Korea. Direct medical costs were calculated from health care claims obtained from Seoul National University Hospital, which included out-of-pocket expenditures. Direct non-medical and indirect costs were calculated from national statistics. Results: Mean direct medical costs, direct non-medical costs, and indirect costs amounted to $21,321, $6444 and $4943 respectively, based on an exchange rate of Korean Won 1200 = US $1. The average cost for treatment of one lung cancer patient for all 5 years was $32,708. This constituted 44.7% of the per capita income during the same 5-year period. Conclusion: The economic burden of lung cancer treatment is significant in Korea. Crown Copyright (C) 2009 Published by Elsevier Ireland Ltd. All rights reserved.
- Files in This Item: There are no files associated with this item.